FDA grants accelerated approval to linvoseltamab-gcpt for relapsed or refractory multiple myeloma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-linvoseltamab-gcpt-relapsed-or-refractory-multiple-myeloma?utm_medium=email&utm_source=govdelivery